Literature DB >> 1637889

Parvovirus B19 infection and bone marrow transplantation.

N Frickhofen1, R Arnold, B Hertenstein, M Wiesneth, N S Young.   

Abstract

Parvovirus B19 lytically infects erythroid progenitor cells and thereby causes cessation of erythropoiesis in infected individuals. Anemia develops only if red cell turnover is increased, as in patients with chronic hemolysis (transient aplastic crisis). In addition to transient marrow failure, B19 can cause chronic anemia and, rarely, pancytopenia in immunodeficient patients who are not able to mount an adequate immune response to clear the virus. Bone marrow transplantation, although causing significant immunosuppression, is rarely complicated by symptomatic B19 infection. This is probably due to effective passive immunotherapy by immunoglobulin infusions immediately after transplantation and early reconstitution of antibody responses after uncomplicated transplantation.

Entities:  

Mesh:

Year:  1992        PMID: 1637889     DOI: 10.1007/bf01715363

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  27 in total

1.  Reconstitution of antibody response after allogeneic bone marrow transplantation: effect of lymphocyte depletion by counterflow centrifugal elutriation on the expression of hemagglutinins.

Authors:  B M Bär; G W Santos; A D Donnenberg
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

2.  Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient.

Authors:  H T Weiland; M M Salimans; W E Fibbe; P M Kluin; B J Cohen
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

3.  Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.

Authors:  O Bartolomei Corsi; A Azzi; M Morfini; R Fanci; P Rossi Ferrini
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

4.  Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation.

Authors:  T Takahashi; K Ozawa; K Takahashi; S Asano; F Takaku
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

5.  The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.

Authors:  K Ozawa; J Ayub; S Kajigaya; T Shimada; N Young
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

7.  [Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation].

Authors:  H Niitsu; H Takatsu; I Miura; A Chubachi; T Ito; M Hirokawa; Y Endo; A Miura; M Fukuda; T Sasaki
Journal:  Rinsho Ketsueki       Date:  1990-09

8.  Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins.

Authors:  P Caillet-Fauquet; M Perros; A Brandenburger; P Spegelaere; J Rommelaere
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

9.  Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro.

Authors:  N Young; M Harrison; J Moore; P Mortimer; R K Humphries
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver.

Authors:  N Yaegashi; H Shiraishi; T Takeshita; M Nakamura; A Yajima; K Sugamura
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

View more
  4 in total

1.  Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant.

Authors:  Arundathi Kurukulasuriya; Amal A Hamed; Muhanna Al-Muslahi; Asaid Ibrahim
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

Review 2.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Human parvovirus B19-associated disease in bone marrow transplantation.

Authors:  M Schleuning; G Jäger; E Holler; W Hill; C Thomssen; C Denzlinger; T Lorenz; G Ledderose; W Wilmanns; H J Kolb
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 7.455

4.  Parvoviruses in blood donors and transplant patients, Italy.

Authors:  Daniela Vallerini; Patrizia Barozzi; Chiara Quadrelli; Raffaella Bosco; Leonardo Potenza; Giovanni Riva; Gina Gregorini; Silvio Sandrini; Andrea Tironi; Giuliano Montagnani; Marisa De Palma; Giuseppe Torelli; Eric Delwart; Mario Luppi
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.